These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 37496074)
1. Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview. Catumbela CSG; Giridharan VV; Barichello T; Morales R Transl Neurodegener; 2023 Jul; 12(1):37. PubMed ID: 37496074 [TBL] [Abstract][Full Text] [Related]
2. The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides. Li F; Hearn M; Bennett LE Crit Rev Microbiol; 2021 Mar; 47(2):240-253. PubMed ID: 33555958 [TBL] [Abstract][Full Text] [Related]
3. Time to test antibacterial therapy in Alzheimer's disease. Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495 [TBL] [Abstract][Full Text] [Related]
4. Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease. Brody DL; Jiang H; Wildburger N; Esparza TJ Alzheimers Res Ther; 2017 Aug; 9(1):62. PubMed ID: 28818091 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
9. Pathology of clinical and preclinical Alzheimer's disease. Thal DR; von Arnim C; Griffin WS; Yamaguchi H; Mrak RE; Attems J; Upadhaya AR Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S137-45. PubMed ID: 24077890 [TBL] [Abstract][Full Text] [Related]
10. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease. Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007 [TBL] [Abstract][Full Text] [Related]
11. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684 [TBL] [Abstract][Full Text] [Related]
12. ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies. Volloch V; Rits-Volloch S Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892224 [TBL] [Abstract][Full Text] [Related]
13. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764 [TBL] [Abstract][Full Text] [Related]
14. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related]
15. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
16. What Do Recent Clinical Trials Teach Us About the Etiology of AD. Robakis NK Adv Exp Med Biol; 2020; 1195():167. PubMed ID: 32468473 [TBL] [Abstract][Full Text] [Related]
17. Age, sex and Alzheimer's disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients. Barber AJ; Del Genio CL; Swain AB; Pizzi EM; Watson SC; Tapiavala VN; Zanazzi GJ; Gaur AB Alzheimers Res Ther; 2024 Jun; 16(1):134. PubMed ID: 38909241 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease. Dunham SJB; McNair KA; Adams ED; Avelar-Barragan J; Forner S; Mapstone M; Whiteson KL mBio; 2022 Dec; 13(6):e0179422. PubMed ID: 36468884 [TBL] [Abstract][Full Text] [Related]
19. Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microglia. Walker DG; Whetzel AM; Lue LF Neuroscience; 2015 Aug; 302():121-37. PubMed ID: 25286386 [TBL] [Abstract][Full Text] [Related]
20. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease. Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM Cells; 2021 Apr; 10(4):. PubMed ID: 33916001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]